Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Capra Science Antibodies AB
AB
Active
Org 5567200927
Ingelstorpsvägen 229
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2007
3 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 5,5M
+6% vs 2023
EBITDA margin
13.6%
+29% vs 2023
Equity ratio
57.1%
Financial strength
Net profit 2024
SEK 112K
-6% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2020
1M
+100%
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 5,5M
+6%
EBITDA
SEK 745K
+29%
Net profit
SEK 112K
-6%
Total assets
SEK 4,6M
+17%
Equity
SEK 2,6M
+4%
Employees
3
—
Company information
Legal name
Capra Science Antibodies AB
Org number
5567200927
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11 januari 2007
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska producera antikroppar samt därmed förenlig verksamhet.
Contact
Address
Ingelstorpsvägen 229
Email
lovisa.hessle@caprascience.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Ängelholm
All Sweden companies
Revenue
SEK millions
0M
2M
3M
5M
7M
5M
2020
6M
2021
6M
2022
5M
2023
5M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
1M
2022
1M
2023
1M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
5 349
5 776
5 771
5 166
5 474
Staff expenses
—
—
−1 545
−1 897
—
EBITDA
408
840
952
577
745
Depreciation & amort.
−162
−210
−261
−342
−516
EBIT
246
630
691
235
229
Net financials
−11
−7
−12
−35
−44
Profit before tax
235
623
679
150
141
Tax
−53
−128
−136
−31
−29
Net profit
182
495
543
119
112
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 640
3 289
4 758
3 897
4 579
Equity
1 348
1 842
2 385
2 504
2 616
Long-term debt
0
0
510
371
809
Short-term debt
1 292
1 447
1 863
972
1 059
Total debt
1 292
1 447
2 373
1 343
1 868
Financial ratios
5-year trend
EBITDA margin
13.6%
This company
15.8%
Market median
-14% vs market
2020
2024
Equity ratio
57.1%
This company
38.2%
Market median
+49% vs market
2020
2024
Return on equity
4.3%
This company
18.4%
Market median
-77% vs market
2020
2024
Net profit margin
2.0%
This company
8.1%
Market median
-75% vs market
2020
2024
Asset turnover
1.20×
This company
1.12×
Market median
+7% vs market
2020
2024
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
BA
Bengt Anders Melander
Audit
Audit
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LM
Lovisa Marianne Hessle Bergman
Board of Directors
2020
LH
Lars Henrik Bergman
Deputy Board Member
2024
Former (1)
BB
Björn Birger Hessle
Chairman
2020 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Capra Science Antibodies AB also hold positions in
0
other companies.
Person
Role here
Other companies
Bengt Anders Melander
Audit
0 companies
Lovisa Marianne Hessle Bergman
Board of Directors
0 companies
Lars Henrik Bergman
Deputy Board Member
0 companies
Björn Birger Hessle
Chairman
0 companies